The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 31 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Sponsored Research Agreement with Eisai Inc
Grant: GM111726
Sponsored Research Agreement with Eisai Inc
Grant: TL1 TR002647
Sponsored Research Agreement with Eisai Inc
Grant: 5R25GM095480
NIH HHS
Grant: TR002647
Eisai Inc
Grant: 167636
NIGMS NIH HHS
Grant: K12 GM111726
National Institutes of Health
Grant: 5P30CA054174-16
SAN ANTONIO CANCER INSTITUTE
National Institutes of Health
Grant: 1K12GM111726-01
San Antonio Biomedical Education and Research
National Institutes of Health
Grant: 1UL1TR002645-01
Institute for Integration of Medicine & Science: A Partnership to Improve Health
National Institutes of Health
Grant: 5R25GM095480-03
Recruiting and Retaining URM Students
National Institutes of Health
Grant: 1TL1TR002647-01
NRSA Training Core (TL1)
FWCI
2.04
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals